StemCells Inc. is looking to tackle Alzheimer’s disease.
The Palo Alto company (NASDAQ: STEM) said Monday that it will work with Frank LaFerla of the University of California, Irvine, to study the use of its human neural stem cells in Alzheimer’s. LaFerla is director of UC, Irvine’s Institute for Memory Impairments and Neurological Disorders.
No comments:
Post a Comment